Internal Server Error

Genospace - About the company

Genospace is an acquired company based in Boston (United States), founded in 2011 by John Quackenbush. It operates as a Bridging clinical research and care with data-driven precision medicine. Genospace has raised $5M in funding from Thomson Reuters. The company has 4062 active competitors, including 452 funded and 368 that have exited. Its top competitors include companies like athenahealth, Modernizing Medicine and Guardant Health.

Company Details

Bridging clinical research and care with data-driven precision medicine. We empower personalized medicine at scale by integrating clinical, genomic, and real-world data. Our technology and services enable informed decisions, personalized treatment strategies, and improved patient outcomes. We focus on clinical trial matching, EMR integration, and study feasibility to connect patients with targeted therapies and research opportunities. We develop innovative tools that push the envelope in research, clinical development, and patient care in areas such as oncology and rare diseases. Our platform supports community oncology practices by seamlessly integrating biomarker data into everyday workflows. We are a software company offering data science solutions, enabling precision medicine through data-driven technologies.
Social
X
Email ID
*****@genospace.com
Registered Address
Boston,massachusetts,united states
Key Metrics
Founded Year
2011
Location
Boston, United States
Stage
Acquired
Total Funding
$5M in 4 rounds
Ranked
Employee Count
42 as on Jun 30, 2026
Similar Companies
Exit Details
Acquired by Sarah Cannon (Jan 12, 2017)

Genospace's acquisition details

Genospace got acquired by Sarah Cannon on Jan 12, 2017.
Click here to take a look at Genospace's acquisition in detail
Sign up to download Genospace's company profile

Genospace's funding and investors

Genospace has raised a total funding of $5M over 4 rounds. Its first funding round was on May 08, 2014. Its latest funding round was a Grant (prize money) round on Sep 23, 2014 for $*****. 1 investor participated in its latest round. Genospace has 5 institutional investors.

Here is the list of recent funding rounds of Genospace:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Sep 23, 2014
1219138
Grant (prize money)
7774595
7921213
4828723
1952989
Sep 15, 2014
8402536
Grant (prize money)
6889976
9052712
8199396
Aug 14, 2014
6491760
Series A
1335326
4104062
1394160
lockAccess funding benchmarks and valuations. Sign up today!

Genospace's founders and board of directors

Founder? Claim Profile
The founders of Genospace is John Quackenbush.
Here are the details of Genospace's key team members:

Genospace's employee count trend

Genospace has 42 employees as of Jun 26. Here is Genospace's employee count trend over the years:
Employee count trend for Genospace
lockUncover Genospace's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Genospace's Competitors and alternates

Top competitors of Genospace include athenahealth, Modernizing Medicine and Guardant Health. Here is the list of Top 10 competitors of Genospace, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for athenahealth
athenahealth
1997, Watertown (United States), Acquired
Cloud-based administrative tool for healthcare providers
$49.1M
87/100
2nd
Logo for Modernizing Medicine
Modernizing Medicine
2010, Boca Raton (United States), Acquired
AI and cloud-based EMR and practice management software for clinics
$329M
81/100
3rd
Logo for Guardant Health
Guardant Health
2012, Redwood City (United States), Public
Developer of digital sequencing technology for cancer detection
$557M
79/100
4th
Logo for Natera
Natera
2004, Redwood City (United States), Public
Developer of cell-free DNA testing for oncology, women’s health, and organ health
$152M
77/100
5th
Developer of molecular diagnostics and personalized medicine for cancer
-
72/100
6th
Logo for MedGenome
MedGenome
2013, Bengaluru (India), Series E
Provider of DNA sequencing, bioinformatics, and multiomics services
$264M
71/100
7th
Logo for Foundation Medicine
Foundation Medicine
2010, Cambridge (United States), Acquired
Provider of genomics-based diagnostics test for cancer
$96.5M
71/100
8th
Logo for Exact Sciences
Exact Sciences
1995, Madison (United States), Acquired
Provider of non-invasive molecular diagnostic testing solutions for cancer
-
71/100
9th
Logo for Caris Life Sciences
Caris Life Sciences
1996, Irving (United States), Public
Developer of panomic disease profiling technologies for cancer precision medicine
$1.23B
70/100
10th
Logo for Prenetics
Prenetics
2009, Hong Kong (China), Public
Online platform for genetic and diagnostic health testing that helps identify health risks
$67.6M
70/100
472nd
Logo for Genospace
Genospace
2011, Boston (United States), Acquired
Bridging clinical research and care with data-driven precision medicine
$5M
37/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Genospace's competitors? Click here to see the top ones

Genospace's Investments and acquisitions

Genospace has made no investments or acquisitions yet.

Reports related to Genospace

Here is the latest report on Genospace's sector:

News related to Genospace

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Genospace

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford